DK258789A - Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet - Google Patents

Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet Download PDF

Info

Publication number
DK258789A
DK258789A DK258789A DK258789A DK258789A DK 258789 A DK258789 A DK 258789A DK 258789 A DK258789 A DK 258789A DK 258789 A DK258789 A DK 258789A DK 258789 A DK258789 A DK 258789A
Authority
DK
Denmark
Prior art keywords
hiv
peptides
binding
block
receptor protein
Prior art date
Application number
DK258789A
Other languages
Danish (da)
English (en)
Other versions
DK258789D0 (da
Inventor
Patricia E Rao
Bradford A Jameson
Stephen B H Kent
Original Assignee
Ortho Pharma Corp
California Inst Of Techn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp, California Inst Of Techn filed Critical Ortho Pharma Corp
Publication of DK258789D0 publication Critical patent/DK258789D0/da
Publication of DK258789A publication Critical patent/DK258789A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70514CD4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK258789A 1988-05-27 1989-05-26 Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet DK258789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19997388A 1988-05-27 1988-05-27

Publications (2)

Publication Number Publication Date
DK258789D0 DK258789D0 (da) 1989-05-26
DK258789A true DK258789A (da) 1989-11-28

Family

ID=22739793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258789A DK258789A (da) 1988-05-27 1989-05-26 Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet

Country Status (6)

Country Link
EP (1) EP0344006A3 (fr)
JP (1) JPH02131497A (fr)
AU (1) AU626865B2 (fr)
DK (1) DK258789A (fr)
PT (1) PT90657B (fr)
ZA (1) ZA894024B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168698T1 (de) * 1988-05-27 1998-08-15 Us Health Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
JPH03254693A (ja) * 1990-03-06 1991-11-13 Calpis Food Ind Co Ltd:The 抗イデオタイプ抗体作製用抗原、抗イデオタイプ抗体、及びその製法
CA2041271A1 (fr) * 1990-04-30 1991-10-31 Bradford A. Jameson Peptides analogues aux proteines de la grande famille des immunoglobines
JPH05262662A (ja) * 1991-07-15 1993-10-12 Calpis Food Ind Co Ltd:The Hiv重感染防止剤、抗イディオタイプ抗体作製用抗原及び抗イディオタイプ抗体の製造法
WO1994000488A1 (fr) * 1992-06-23 1994-01-06 Sumitomo Pharmaceuticals Company, Limited Peptide anti vih ou derives de ce peptide
FR2694938B1 (fr) * 1992-08-10 1996-11-15 Zagury Jean Francois Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
FR2694560B1 (fr) * 1992-08-10 1995-06-30 Zagury Jean Francois Nouveaux peptides viraux, anticorps diriges contre ces peptides, procede de preparation, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
DE4447484C2 (de) * 1994-04-08 1997-07-17 Deutsches Krebsforsch Mittel zur Hemmung von Apoptose
US5968753A (en) * 1994-06-14 1999-10-19 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
EP1460088A1 (fr) 2003-03-21 2004-09-22 Biotest AG Anticorps humanisé contre CD4 avec des caractéristiques immunosuppressives
MX2010010028A (es) 2008-03-13 2011-08-17 Biotest Ag Agente para tratar enfermedad.
SG190627A1 (en) 2008-03-13 2013-06-28 Biotest Ag Agent for treating disease
EP2262838B1 (fr) 2008-03-13 2016-04-13 Biotest AG Agent pour traiter une maladie
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005935A1 (fr) * 1986-04-04 1987-10-08 Battelle Memorial Institute At Columbus, Ohio Gene Procedes et compositions d'expression de produits genetiques eucaryotiques competitifs
PT88783B (pt) * 1987-10-23 1993-01-29 Smithkline Beckman Corp Processo de purificacao de proteina t4 soluvel e de producao da mesma

Also Published As

Publication number Publication date
ZA894024B (en) 1991-01-30
DK258789D0 (da) 1989-05-26
AU3526689A (en) 1989-11-30
PT90657B (pt) 1995-03-01
EP0344006A3 (fr) 1990-08-16
JPH02131497A (ja) 1990-05-21
AU626865B2 (en) 1992-08-13
EP0344006A2 (fr) 1989-11-29
PT90657A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
DK258789A (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
DK264889A (da) To-fase-cementblanding, isaer til ortopaediske anvendelser
DK118887D0 (da) Fremgangsmaade til indvinding af mikrobielt produceret, rekombinant, oploeseligt ricintoxin-a-kaede
DK2691A (da) Peptider, der binder retroviral protease
DK54184A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af human (interleukin) to-lignende polypeptider
DK74387A (da) Sammenfoejningsorgan til sammenfoejning af traebjaelker
DK22387D0 (da) Fremgangsmaade til fremstilling af ethanol
DK434987D0 (da) Fremgangsmaade til fremstilling af polypeptider
NO890774D0 (no) Ekspresjon av hiv-bindende proteiner.
DE69028783D1 (de) Künstliche peptide, die die zellbindung steigern
DK200489D0 (da) Fremgangsmaade til fremstilling af polypeptider
KR900701829A (ko) 봄베신 수용체에 대한 비가역적 펩타이드 리간드
DK489683A (da) Fremgangsmaade til fremstilling af peptider
DK68784A (da) Kontinuert fremgangsmaade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler
DK34888A (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK19889D0 (da) Fremgangsmaade til fremstilling af polypeptider
DE3787927D1 (de) Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken.
MA21633A1 (fr) Sunthese peptidiques en phase solide.
DK84987A (da) Kontinuerlig fremgangsmaade til fremstilling af o,o-di-la-vere-alkylchlorthiophosphat
NO895235D0 (no) Syntetiske peptider beslektet med hiv-env-proteiner.
NO910053D0 (no) Retrovirusprotease-bindende peptider.
NO880446D0 (no) Smaa peptider som inhiberer binding til t-4-reseptorer.
NO920318L (no) Retrovirusprotease-bindende peptider
NO920319L (no) Retrovirusprotease-bindende peptider
DK664089A (da) Fremgangsmaade til fremstilling af l-alanin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment